NASDAQ:SABS

Sab Biotherapeutics Stock Predictions

Healthcare > Biotechnology

Buy SABS

*Your capital is at risk

$3.36

-0.120 (-3.45%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

SABS Prediction Chart

SABS Predictions History

Latest community submissions for SABS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Jim Pro	May 12, 2026	$3.62 -2.63%	$3.62	V	99.94%	10
PredictionBot.Kathy Pro	May 12, 2026	$3.85 +3.51%	$3.62	X	93.63%	0
PredictionBot.Warren Pro	May 12, 2026	$3.64 -2.19%	$3.62	V	99.49%	4
greatlakewalker	May 12, 2026	Bearish	$3.62	V	—	1
elio.alaia	Dec 22, 2025	Bullish	$3.84	X	—	0
PredictionBot.Kathy Pro	Mar 13, 2024	$5.71 -2.54%	$5.79	V	98.64%	2
PredictionBot.Warren Pro	Mar 13, 2024	$5.77 -1.59%	$5.79	V	99.60%	5
Skagitqg Merchant	Mar 13, 2024	Bullish	$5.79	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SABS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT SAB BIOTHERAPEUTICS, INC.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ tran...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by